1. Home
  2. VTSI vs CTMX Comparison

VTSI vs CTMX Comparison

Compare VTSI & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VirTra Inc.

VTSI

VirTra Inc.

HOLD

Current Price

$4.78

Market Cap

61.9M

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$4.16

Market Cap

596.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTSI
CTMX
Founded
1993
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
61.9M
596.2M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
VTSI
CTMX
Price
$4.78
$4.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$7.00
$6.50
AVG Volume (30 Days)
56.4K
2.0M
Earning Date
11-10-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
50.22
EPS
0.01
0.24
Revenue
$24,934,267.00
$113,631,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$13.39
N/A
P/E Ratio
$331.53
$17.32
Revenue Growth
N/A
N/A
52 Week Low
$3.57
$0.40
52 Week High
$7.49
$4.62

Technical Indicators

Market Signals
Indicator
VTSI
CTMX
Relative Strength Index (RSI) 35.80 57.36
Support Level $4.79 $3.78
Resistance Level $5.13 $4.20
Average True Range (ATR) 0.14 0.24
MACD 0.01 -0.02
Stochastic Oscillator 7.55 73.88

Price Performance

Historical Comparison
VTSI
CTMX

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: